Literature DB >> 19380668

Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed.

Andrew H Kalajian1, Paula S Malhotra, Jeffrey P Callen, Lynn P Parker.   

Abstract

BACKGROUND: Calciphylaxis is a life-threatening form of metastatic calcification-induced microvascular occlusion syndrome. Although traditionally observed in patients with end-stage renal disease and/or hyperparathyroidism, the development of calciphylaxis in "nontraditional" patients having both normal renal and parathyroid function has been reported. However, to date there has been no collective analysis identifying common patient characteristics potentially predisposing to the development of calciphylaxis in nontraditional patients. OBSERVATIONS: A 58-year-old woman with endometrial carcinoma developed extensive calciphylaxis despite the presence of normal renal and parathyroid function. The disease resolved with rapid diagnosis, supportive therapy, and medical management. Analysis of this case and the 13 previously reported cases of nontraditional calciphylaxis identified the following patient characteristics that highlight clinical situations potentially predisposing to calciphylaxis: hypoalbuminemia, malignant neoplasm, systemic corticosteroid use, anticoagulation with warfarin sodium or phenprocoumon, chemotherapy, systemic inflammation, hepatic cirrhosis, protein C or S deficiency, obesity, rapid weight loss, and infection.
CONCLUSIONS: Calciphylaxis is becoming increasingly common in patients with normal renal and parathyroid function. The observations from this study may assist dermatologists in the rapid diagnosis and prompt initiation of therapy for this devastating disease.

Entities:  

Mesh:

Year:  2009        PMID: 19380668     DOI: 10.1001/archdermatol.2008.602

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  19 in total

Review 1.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

Review 2.  Calciphylaxis: from the disease to the diseased.

Authors:  Tiago M Oliveira; João M Frazão
Journal:  J Nephrol       Date:  2015-04-03       Impact factor: 3.902

Review 3.  [Calciphylaxis. A call for interdisciplinary cooperation].

Authors:  V M Brandenburg; S Schmitz; J Floege; K Amann; M Ketteler
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

4.  A case report: radiological findings in an unusual case of calciphylaxis 16 years after renal transplantation.

Authors:  Sarahn Smith; Akimichi Inaba; Joseph Murphy; Gary Campbell; Andoni P Toms
Journal:  Skeletal Radiol       Date:  2013-06-11       Impact factor: 2.199

5.  Calciphylaxis: a severe complication of renal disease.

Authors:  Nina Scola; Alexander Kreuter
Journal:  CMAJ       Date:  2011-08-15       Impact factor: 8.262

6.  Calciphylaxis in the absence of renal failure and hyperparathyroidism in a nonagenarian.

Authors:  Shuang Quan Chan; Irene Wagner; Grace Sylvia Vittor
Journal:  BMJ Case Rep       Date:  2015-04-15

7.  [Calciphylaxis. A less well-known, clinically relevant disease].

Authors:  J D Strehl; V Brandenburg; C Forster; C Willam; A Hartmann; K Amann
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

8.  Calcific Uremic Arteriolopathy Revisited.

Authors:  Anna Jovanovich; Michel Chonchol
Journal:  J Am Soc Nephrol       Date:  2016-05-25       Impact factor: 10.121

Review 9.  Warfarin-Associated Nonuremic Calciphylaxis.

Authors:  Wesley Yung-Hsu Yu; Tina Bhutani; Rachel Kornik; Laura B Pincus; Theodora Mauro; Michael D Rosenblum; Lindy P Fox
Journal:  JAMA Dermatol       Date:  2017-03-01       Impact factor: 10.282

10.  Sodium thiosulfate in the treatment of calciphylaxis.

Authors:  George F Cohen; Nikki S Vyas
Journal:  J Clin Aesthet Dermatol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.